Subscribe to the newsletterForward | Contact | www.lyonbiopole.com   July 2014
 
A LA UNE
07/22/2014 - Success for the first Horizon 2020 Health Brokerage Event, in Lyon

On July 4, the Horizon 2020 Health National Contact Point, the Industrial Chamber of Commerce (CCI) of Lyon member of the Enterprise Europe Network, Lyonbiopole the competitiveness cluster devoted to health in Rhône-Alpes, with the support of Rhône-Alpes Region welcomed in Lyon 200 participants from all over Europe, for the first Horizon 2020 Health Brokerage Event. On this occasion, 250 face-to-face appointments were organized to promote the constitution of future H2020 consortia. 
 

Learn more


10/10/2014 - Partnering Days and BlueSky Meeting : registration are opened 

Partnering Days 2014 will be held Friday, October 10, 2014 at the Congress Center of the WTC Grenoble. Registration are opened. This day is designed to allow exchanges between health actors in Rhône-Alpes and facilitate the emergence of new collaborations. This new edition should bring the majority of health actors in Rhône-Alpes from industrial sectors, SMEs, academic and hospital. It will be organized around two key tools: thematic roundtables and brainstorming project ideas and technology offerings for SMEs at BlueSky Meeting sessions flash presentation.
Contact: Claudia Chagneau, R&D Project Manager - claudia.chagneau@lyonbiopole.com 

Learn more


10/19-24/2014 - Health Mission to China

Lyonbiopole in partnership with ERAI and with the support of the Rhône-Alpes Region, is organizing a mission to China from October 19th to 24th, 2014. This missions fully integrated to the support actions carried out since 2009 by Lyonbiopole on the Chinese market. This year, it benefits from the venue of the Rhone-Alpes region President, M. Jean-Jack Queyranne, who will visit Shangai, therefore, offering an increased visibility for participating SMEs. This mission is built around a program of individual business meetings divided between Shanghai and Beijing and the participation in the official delegation of the President in Shanghai.
Contact: Simon PICO, China Project Manager - simon.pico@lyonbiopole.com  


ZOOM SUR
ImmunID

ImmunID, member of Lyonbiopole and based in Grenoble, is an immune molecular diagnostics company which develops and commercializes immune competence tests. The company recently announced the launch of a new study with the “Singapore Immunology Network” about the link between immune competence and patient response. ImmunID also strengthened its Scientific and Advisory Board with Dr Miguel Perales, Deputy Chief, Adult Bone Marrow Transplant Service at Memorial Sloan Kettering Cancer Center in New York. 

Learn more



A LA UNE
09/23/2014 - TechDays Health
 

The second edition of TechDays Health will be held in Lyon September 23, 2014. This day is organized by the I-Care Cluster in partnership with Lyonbiopole, Plastipolis, Imaginove and Minalogic, the Cancéropole CLARA, Neurodis Foundation and ARDI Rhône-Alpes. The event converges in the field of health technology designers DM, their subcontractors, as well as research organizations and clinical reference centers around the theme of ambulatory theme of this edition thread.
Contact: Claudia Chagneau, R&D Project Manager - claudia.chagneau@lyonbiopole.com

Learn more


11/3-5/2014 - Bio Europe 2014 

In the upcoming BIO EUROPE, which will take place in Frankfurt from November 3 to 5, 2014, Lyonbiopole, through its partnership with Ubifrance and EBD, make you benefit from various discounts on access to the convention. Moreover, in the context of this event, the industry experts in our network are at your disposal to accompany you on your respective markets and optimize your chances of success. 
Contact: Simon Gudin, SMEs Development Project Manager - simon.gudin@lyonbiopole.com

Learn more


11/12-15/2014 - MEDICA-COPAMED Exhibition

Lyonbiopole and I-Care Clusterin partnership with UbiFrance invite companies in the Rhône-Alpes region to participate in MEDICA COPAMED-2014 Exhibition will be held from 12 to 15 November 2014 in Düsseldorf (Germany). Visit Europe's largest conference on the theme MedcialesTechnologies & Medical Devices.
Contact: Simon Gudin, SMEs Development Project Manager – simon.gudin@lyonbiopole.com

Learn more


11/28/2014 - 6th edition of the Lyonbiopole’s Private Inv€stment Day, Save the date !

For the 6th time, Lyonbiopole organizes the Private Inv€stment Day on Friday, November 28th 2013, from 8.00 am to 3.00 pm. This event, dedicated to SMEs and private investors aims to foster interactions between companies, new entrepreneurs and investors of every kind. This day will be organized around moments of networking (roundtables, testimony and breaks) and company and project presentations.
Contact: Kevin Romani, SMEs Developement Director - kevin.romani@lyonbiopole.com

Learn more



AGENDA
Partnering Days & BlueSky Meeting
October 10th 2014 - Grenoble, France
Bio-Europe 2014
From November 3 to 5, 2014 - Frankfurt, Germany
Medica Copamed
From november 12 to 15 - Dusseldorf, Germany
4th Munich Biomarker Conference
From November 25 to 26, 2014 - Munich, Germany
Private Inv€stment Day
November 28th, 2014 - Lyon, France
 
A LA UNE
04/2014 - New Eurostars 2 call for projects

The new Eurostars 2 call for projects is open. This funding programme is fully dedicated to innovative SMEs aiming to launch R&D projects closed to the market, that are collaborative and European (at least 2 partners from EU). The funding rate for projects goes from 30 to 40% (subsidy managed by BPI France). Thus the new Eurostars 2 call for project is launched, which submission deadline is planned on Sept. 11, 2014. Lyonbiopole supports you for EU project set-up thanks to its ETP programme.
Contact: Emilie Romeo, European Project Manager - emilie.romeo@lyonbiopole.com

Learn more


05/2014 - Open calls Horizon 2020

The European commission has launched in December 11th 2013, the 1st Horizon 2020 (EU research and innovation programme for 2014-2020) calls for projects. Many calls are open at the moment: FET OPEN (disruptive innovation), SME Instrument (with several deadlines), “Health, demographic change and wellbeing” calls. Lyonbiopole supports you to build European projects through its ETP program.
Contact: Emilie Romeo, European Project Manager - emilie.romeo@lyonbiopole.com

Learn more


06/2014 - Call for proposals "Innovation Vouchers" Health2CARE

Lyonbiopole is partner in a new European project Health2CARE funded for a period of 2 years by DG Enterprise (CE) alongside the Rhône-Alpes Region, I-CARE cluster, Minalogic and Plastipolis. In this context, the consortium has launched a call for proposals to foster the emergence of innovative solutions led by SMEs in the Rhône-Alpes region in the field of personalized medicine. New deadline for submission: 09/03/2014. A jury of European experts will assess the applications in the coming weeks. The most promising projects will receive financial support called "Innovation Vouchers" and thus benefit from external expertise for their development (support to business development, IP expertise etc..). Find the call details by clicking here.
Contact: Emilie Romeo, European Project Manager - emilie.romeo@lyonbiopole.com

Learn more


07/09/2014 - IMI will launch its first IMI 2 calls on July 9

The Innovative Medicines Initiative (IMI) launched its first call for projects under the IMI 2 on July 9. The topics proposed in the first call are: - Translational Approaches to disease modifying therapy of type 1 diabetes mellitus / - Discovery and validation of novel endpoints dry age-related macular degeneration and diabetic retinopathy. Deadline for submission: November 12, 2014. Find all the details on the IMI website. Several information sessions are planned, including one Infoday in Brussels on 09/30. Also, webinars are scheduled in July (dates are available on the IMI website). IMI advises SMEs, patient organizations, regulatory authorities, academic teams, industry, hospitals and other organizations with an interest in IMI projects to participate in webinars. Lyonbiopole supports you to answer European calls through its ETP program. 
Contact: Emilie ROMEO, European Project Manager -emilie.romeo@lyonbiopole.com

Learn more



A LA UNE
07/23/2014 - Winner of Global Innovation Competition

EndoControl announced that the project led by its President Clément Vidal has been selected for the global innovation competition, in the category "Individualized Medicine". The ARCC project (Assistance Robotics Co-operation for Surgery) robotchirurgien of intelligent interaction was chosen by the commission "Innovation 2030", chaired by Anne Lauvergeon.

07/22/2014 - Erytech announces enrollment of first patient in Phase I/II study in the United States

ERYTECH Pharma announced the enrollment of the first patient in its Phase I/II study ERY-ASP in Acute Lymphoblastic Leukemia in the United States of America.

Learn more


07/21/2014 - ABL, Inc. Acquires Majority Interest in Platine Pharma Services

ABL, a biomedical contract research and manufacturing organization to the biopharmaceutical industry, is pleased to announce the acquisition of a majority interest in Platine Pharma Services (Platine), a specialist in immunomonitoring and immunogenicity services.

Learn more


07/09/2014 - Adocia announces phase IIa Clinical Study of HinsBet®

Adocia announced that BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte), the German regulatory agency for drugs and medical devices, has approved the initiation of a Phase IIa clinical study of HinsBet®, a fast-acting formulation of human insulin. 

Learn more


07/02/2014 - genOway offers industry scientists immediate access to EUCOMM conditional KO mouse models

genOway announced the signing of a license enabling genOway to provide industry scientists with conditional knockout (KO) models developed by EUCOMM. 

Learn more


06/16/2014 - Calixar to extend its portfolio of strategic compounds

CALIXAR announced the issue of a new generation of compounds able to extract and stabilize complex pharmaceutical targets. 

Learn more

 
© Lyonbiopole 2019  |  CREDITS  |  LEGAL NOTICE  |